Alzheimer's disease: Visual system review

Hebert, 2003, Alzheimer's disease in the us population: prevalence estimates using the 2000 census, Arch Neurol, 60, 1119, 10.1001/archneur.60.8.1119 CDC. US deaths down sharply in 2006. In: Statistics NCH ed. Washington DC: Department of Health and Human Services, 2008. Available at: http://www.cdc.gov/media/pressrel/2008/r080611.htm. Alzhiemer's. Alzheimer's disease facts and figures (2008) Comprehensive statistical abstract of U.S. data on Alzheimer's disease. Available at: http://alz.org/index.asp. Last accessed October 2009. Lewin. Medicare and Medicaid costs for people with Alzheimer's disease. Washington, D.C. April 2001:1. McKee, 2006, Visual association pathology in preclinical Alzheimer disease, J Neuropathol Exp Neurol, 65, 621, 10.1097/00005072-200606000-00010 Valenti DA. Anterior Visual System and circadian function with reference to Alzheimer's disease. In: Cronin-Golomb A, Hof PR, eds. Vision in Alzheimer's disease. Interdisciplinary Topics in Gerontology 2004;34:1–29. Cronin-Golomb, 1991, Visual function in Alzheimer's disease and normal aging, Ann NY Acad Sci, 640, 28, 10.1111/j.1749-6632.1991.tb00186.x Thiyagesh, 2009, The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study, Psychiatry Res, 172 Mapstone, 2008, Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease, Brain, 131, 1618, 10.1093/brain/awn064 Gilmore, 1994, Motion perception and Alzheimer's disease, J Gerontol, 49, P52, 10.1093/geronj/49.2.P52 Armstrong, 1996, Visual field defects in Alzheimer's disease patients may reflect differential pathology in the primary visual cortex, Optom Vis Sci, 73, 677, 10.1097/00006324-199611000-00001 Trick, 1995, Visual field loss in senile dementia of the Alzheimer's type, Neurology, 45, 68, 10.1212/WNL.45.1.68 Cronin-Golomb, 1993, Incomplete achromatopsia in Alzheimer's disease, Neurobiol Aging, 14, 471, 10.1016/0197-4580(93)90105-K Quigley, 1982, Optic nerve damage in human glaucoma III: quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic optic neuropathy, papilledema and toxic optic neuropathy, Arch Ophthalmol, 100, 135, 10.1001/archopht.1982.01030030137016 Pacheco-Cutillas, 1999, Acquired colour vision defects in glaucoma-their detection and clinical significance, Br J Ophthalmol, 83, 1396, 10.1136/bjo.83.12.1396 Shabana, 2003, Motion perception in glaucoma patients: a review, Survey Ophthal, 48, 92, 10.1016/S0039-6257(02)00401-0 Mei, 2007, Suprathreshold contrast matching in maculopathy, Invest Ophthalmol Vis Sci, 48 Feigl, 2005, Monitoring retinal function in early age-related maculopathy: visual performance after one year, Eye 2005, 19, 1169, 10.1038/sj.eye.6701711 Ruppertsberg, 2007, When S-cones contribute to chromatic global motion processing, Vis Neurosci, 24, 1, 10.1017/S0952523807230081 Bayer, 2002, Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease, Eye, 16, 209, 10.1038/sj/eye/6700034 American Foundation for the Blind. Senior Site, Glaucoma Fact Sheet. Available at: http://www.afb.org/seniorsite.asp?SectionID=63&TopicID=286&DocumentID=3198. Last accessed October 2009. National Institutes of Health. Fact Sheet, Glaucoma. Available at: http://www.nih.gov/about/researchresultsforthepublic/glaucoma.pdf. Last accessed October 2009. National Institutes of Health. Prevalence of Blindness Data Tables (NEI Statistics and Data). Available at: http://www.nei.nih.gov/eyedata/pbd_tables.asp Last accessed August 2009. Marshal, 1989, Racial differences in the presentation of chronic open-angle glaucoma, J Am Optome Assoc, 60, 760 Varma, 2004, Prevalence of open angle glaucoma and ocular hypertension in Latinos, Ophthalmology, 111, 1439, 10.1016/j.ophtha.2004.01.025 Glaucoma Research Foundation. Glaucoma Research Foundation Facts and Stats. 2009. Available at: http://www.glaucoma.org/learn/glaucoma_facts.php. Last accessed October 2009. Estermann, 2006, Effect of oral donepezil on intraocular pressure in normotensive Alzheimer patients, J Ocul Pharmacol Ther, 22, 62, 10.1089/jop.2006.22.62 Miki, 2006, Protective effect of donepezil on retinal ganglion cells in vitro and in vivo, Curr Eye Res, 31, 69, 10.1080/02713680500477438 Rabins, 2007, APA Work Group on Alzheimer's Disease And Other Dementias. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias, Am J Psychiatry, 164, 5 Goldblum, 2000, Topical rivastigmine, a selective acetyclcholinesterase inhibitor, lowers intraocular pressure in rabbits, J Ocul Pharmacol Ther, 1, 29, 10.1089/jop.2000.16.29 Molinuevo, 2005, Memantine: Targeting glutamate excitotoxicity in Alzheimer's disease and other dementias, Am J Alzheimer Dis Dementias, 2, 77, 10.1177/153331750502000206 Reisberg, 2003, Memantine in moderate to severe Alzheimer's disease, N Eng J Med, 348, 1333, 10.1056/NEJMoa013128 Tariot, 2004, Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil, JAMA, 291, 317, 10.1001/jama.291.3.317 Yucel, 2006, Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma, Arch Ophthalmol, 124, 217, 10.1001/archopht.124.2.217 Weber, 2000, Experimental glaucoma and cell size, density and number in primate lateral geniculate nucleus, Invest Ophthalmol Vis Sci, 41, 1370 Yucel, 2001, Atrophy of relay neurons in mango-and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma, Invest Opthal Vis Sci, 42, 3216 Gupta, 2006, Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus and visual cortex, Br J Ophthalmol, 90, 674, 10.1136/bjo.2005.086769 Chaturvedi, 1993, Lateral geniculate nucleus in glaucoma, Am J Opthal, 116, 182, 10.1016/S0002-9394(14)71283-8 Alexander, 2001, Contrast discrimination deficits in retinitis pigmentosa are greater for stimuli that favor the magnocellular pathway, Vis Res, 41, 671, 10.1016/S0042-6989(00)00286-8 Hof, 1990, Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex, J Comp Neurol, 301, 55, 10.1002/cne.903010106 Leuba, 1995, Pathology of subcortical visual centres in relation to cortical degeneration in Alzheimer's disease, Neuropathol Appl Neurobiol, 21, 410, 10.1111/j.1365-2990.1995.tb01078.x Buguet, 1994, 24-Hour (nyctohemeral) and sleep-related variations of intraocular pressure in healthy white individuals, Am J Opthalmol, 117, 342, 10.1016/S0002-9394(14)73143-5 Sacca, 1998, Fluctuations of intraocular pressure during the day in open angle glaucoma, normal tension glaucoma and normal individuals, Opthalmoligica, 212, 115, 10.1159/000027290 Little, 1995, Sundown syndrome in severely demented patients with probable Alzheimer's disease, J Geriatr Psychiatry Neurol, 8, 103, 10.1177/089198879500800205 Mirmiran, 1992, Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease, Prog Brain Res, 16, 151, 10.1016/S0079-6123(08)64570-7 Swaab, 1985, The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia, Brain Res, 342, 37, 10.1016/0006-8993(85)91350-2 Bliwise, 1993, Sleep and sundowning in nursing home patients with dementia, Psychiatr Res, 48, 277, 10.1016/0165-1781(93)90078-U Wisor, 2005, Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission, Neuroscience, 131, 375, 10.1016/j.neuroscience.2004.11.018 Zhang, 2005, Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons, Neurobiology, 167, 1361 Noel, 2001, Twenty-four hour time course of intraocular pressure in healthy and glaucomatous Africans: relation to sleep patterns, Ophthalmology, 108, 139 Liu, 1999, Elevation of human intraocular pressure at night under moderate illumination, Invest Ophthal Vis Sci, 40, 2439 Munch, 2006, Wavelength dependent effects of evening light exposure on sleep architecture and sleep EEG power density in men, Physiol Regul Integr Comp Physiol, 290, 1421, 10.1152/ajpregu.00478.2005 Berson, 2002, Phototransduction by retinal ganglion cells that set the circadian clock, Science, 295, 1070, 10.1126/science.1067262 Bayer, 2002, High occurrence rate of glaucoma among patients with Alzheimer's disease, Eur Neurol, 47, 165, 10.1159/000047976 Ou, 2009, Assessing the relationship between open-angle glacouma and Alzheimer's disease, ARVO Annual Meeting Fort Lauderdale Florida Tamura, 2006, High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease, J Neuro Sci, 65 Enzenauer, 2005, Angle-closure glaucoma after discontinuing donepezil hydrochloride (Aricept), J Gerontol A Biol Sci Med Sci, 60, 1083, 10.1093/gerona/60.8.1083 Ferrington, 2006, Different death stimuli evoke apoptosis via multiple pathways in retinal pigment epithelial cells, Exp Eye Res, 83, 638, 10.1016/j.exer.2006.03.003 Sarraf, 1999, Long term drusen study, Retina, 19, 513, 10.1097/00006982-199911000-00006 Jonasson, 2003, The prevalence of age related maculopathy in Iceland: Reykjavik eye study, Arch Ophthalmol, 1, 379, 10.1001/archopht.121.3.379 Klein, 2008, The epidemiology of retinal reticular drusen, Am J Opthalmol, 145(2), 317, 10.1016/j.ajo.2007.09.008 AREDS, 2006, Cognitive impairment in the age related eye disease study, Arch Ophthalmol, 124, 537, 10.1001/archopht.124.4.537 Luibl, 2006, Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers, J Clin Invest, 116, 378, 10.1172/JCI25843 Anderson, 2004, Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration, Exp Eye Res, 78, 243, 10.1016/j.exer.2003.10.011 Yoshida, 2005, The potential role of amyloid beta in the pathogenesis of age-related macular degeneration, J Clin Invest, 115, 2793, 10.1172/JCI24635 Dentchev, 2003, Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas, Molecular Vis, 9, 184 Luibl, 2006, Drusen deposits associated with ging and age-related macular degeneration contain nonfibrillar amyloid oligomers, J Clini Invest, 116, 378, 10.1172/JCI25843 Shahidi, 2006, A method for chorioretinal oxygen tension measurement, Curr Eye Res, 31, 357, 10.1080/02713680600599446 Delori, 2001, Macular pigment density measured by autofluorescence spectrometry: comparison with feflectometry and heterochromatic flicker photometry, J Opt Soc Am A Opt Image Sci Vis, 18, 1212, 10.1364/JOSAA.18.001212 Iseri, 2006, Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer's disease, J Neuro-ophthalmol, 26, 18, 10.1097/01.wno.0000204645.56873.26 Blanks, 1996, Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina, Neurobiol Aging, 17 Dentchev, 2003, Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas, Molecular Vis, 9, 184 Thakkinstian, 2008, Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis, Am J Epidemiol, 9, 813 Malek, 2005, Apolipoprotein E allele-dependent pathogenesis: A model for age-related retinal degeneration, PNAS, 102, 11900, 10.1073/pnas.0503015102 Ding, 2007, Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amylid beta antibody attenuates pathologies in an age-related macular degeneration mouse model, Vis Res, 3, 339 Goldstein, 2003, Cytosolic Beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease, Lancet, 361, 1258, 10.1016/S0140-6736(03)12981-9 Ding, 2007, Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amylid beta antibody attenuates pathologies in an age-related macular degeneration mouse model, Vis Res Melov, 2005, Mice transgenic for Alzheimer disease beta amyloid develop lens cataracts that are rescued by antioxidant treatment, Free Radical Biology and Medicine, 38, 258, 10.1016/j.freeradbiomed.2004.10.023 Collinson, 2004, Spatial characteristics of receptor-induced calcium signaling in human lens capsular bags, Invest Ophthal Vis Sci, 45, 200, 10.1167/iovs.03-0694 Sweeney, 2003, Movement of cysteine in intact monkey lenses: the major site of entry is the germinative region, Exp Eye Res, 77, 245, 10.1016/S0014-4835(03)00110-6 Thomas, 1997, The human lens possesses acetylcholine receptors that are functional throughout life, Exp Ey Res, 64, 849, 10.1006/exer.1996.0243 Shaffer, 1966, Anticholinesterase drugs and cataracts, Am J Opthalmol, 62, 613, 10.1016/0002-9394(66)92181-7 DeRoetth, 1966, Lenticular opacities in glaucoma patients receiving echothiophate iodide therapy, Am J Ophthalmol, 62, 619, 10.1016/0002-9394(66)92182-9 Albrecht, 1979, Early lens changes in Macca fasciularis monkeys under topical treatment with echothiophate or carbachol studied by slit image photography, Invest Ophthal Vis Sci, 18, 8 Durand, 2002, Muscarinic receptor antagonist-induced lenticular opacity in rats, Toxicological Sci, 66, 166, 10.1093/toxsci/66.1.166 1966, Deroetth. Lenticular opacities in glaucoma patients receiving echothiophate iodide therapy, JAMA, 195, 152, 10.1001/jama.1966.03100020140062 Firth, 1973, The influence of miotics on the lens, Ann Ophthalmol, 5, 685 Abraham, 1969, Influence of various miotics on cataract formation, Br J Ophthalmol, 53, 5, 10.1136/bjo.53.12.833 Gomez-Tortosa, 1996, Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders, Acta Neurol Scand, 94, 104, 10.1111/j.1600-0404.1996.tb07038.x Scinto, 1999, Pupil assay and Alzheimer's disease: a critical analysis, Neurology, 52, 673, 10.1212/WNL.52.3.673 Reitner, 1997, The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease, Vis Res, 37, 165, 10.1016/S0042-6989(96)00119-8 Hanyu, 2007, Phenylephrine and pilocarpine eye drop test for dementia with Lewy Bodies and Alzheimer's disease, Neurosci Letters, 414, 174, 10.1016/j.neulet.2006.12.015 Kaneyuki, 1998, Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease, Neurology, 10.1212/WNL.50.3.802 Scinto, 2008, Pupillary hypersensitivity predicts cognitive decline in community dwelling elders, Neurobiol Aging, 29, 222, 10.1016/j.neurobiolaging.2006.10.002 Fotiou, 2007, Pupil reaction to light in Alzheimer's disease: evaluation of pupil size changes and mobility, Aging Clin Exp Res, 19, 364, 10.1007/BF03324716 Scinto, 2001, Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients, Neurobiol Aging, 22, 729, 10.1016/S0197-4580(01)00235-4 Kaufman, 2008, Exp Ey Res, 86, 3, 10.1016/j.exer.2007.10.007 Yucel, 2000, Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma, Arch Opthal, 118, 378, 10.1001/archopht.118.3.378 Pietrini, 1996, Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications, Am J Psychiatry, 153, 1261, 10.1176/ajp.153.10.1261 Curcio, 1993, Retinal ganglion cells in Alzheimer's disease and aging, Ann Neurol, 33, 248, 10.1002/ana.410330305 Sadun, 1990, Optic nerve damage in Alzheimer's disease, Ophthalmology, 97, 9, 10.1016/S0161-6420(90)32621-0 Hinton, 1986, Optic nerve degeneration in Alzheimer's disease, N Eng J Med, 315, 485, 10.1056/NEJM198608213150804 Davies, 1995, Myelintated axon number in the optic nerve is unaffected by Alzheimer's disease, Br J Ophthalmol, 79, 596, 10.1136/bjo.79.6.596 Tsai, 1991, Optic nerve head and nerve fiber layer in Alzheimer's disease, Arch Opthalmol, 109, 199, 10.1001/archopht.1991.01080020045040 Hedges, 1996, Retinal nerve fiber layer abnormalities in Alzheimer's disease, Acta Ophthlmol Scand, 74, 271, 10.1111/j.1600-0420.1996.tb00090.x Parisi, 2001, Morphological and functional retinal impairment in Alzheimer's disease patients, Clin Neurophysiol, 112, 1860, 10.1016/S1388-2457(01)00620-4 Valenti, 2007, Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography, Neurology, 69, 1060, 10.1212/01.wnl.0000280584.64363.83 Bersisha, 2006, Localized retinal nerve fiber layer thinning in patients with early glaucoma or Alzheimer's disease, ARVO Annual Meeting; Fort Lauderdale, Florida Paquet, 2007, Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease, Neurosci Lett, 420, 97, 10.1016/j.neulet.2007.02.090 Mentis, 1996, Visual cortical dysfunction in Alzheimer's Disease evaluated with temporarily graded stress test during PET, Am J Psychiatry, 153, 32, 10.1176/ajp.153.1.32 Mentis, 1998, Increasing required neural response to expose abnormal brain function in mild versus moderate or sever Alzheimer's Disease: PET study using parametric visual stimulation, Am J Psychiatry, 155, 785 Camicioli, 2006, Dual-tasks and walking fast: Relationship to extra-pyramidal signs in advanced Alzheimer disease, J Neurological Sci, 3, 205, 10.1016/j.jns.2006.05.013 Lord, 2001, Visual factors for falls in older people, J Am Geriatr Soc, 49, 508, 10.1046/j.1532-5415.2001.49107.x French, 2006, Drugs and falls in community dwelling older people: A National Veterans Study, Clin Therapeutics, 28, 619, 10.1016/j.clinthera.2006.04.011 Valenti D. Vision assessment in neurodegenerative disease. American Public Health Association National Conference Philadelphia, PA 2005. Tinnetti, 1994, A multifactorial intervention to reduce the risk of falling among elderly people living in the community, N Eng J Med, 331, 821, 10.1056/NEJM199409293311301 Graafmans, 1996, Falls in the elderly: a prospective study of risk factors and risk profiles, Am J Epidemiol, 143, 1129, 10.1093/oxfordjournals.aje.a008690 Marottoli, 1994, Predictors of mortality and institutionalization after hip fracture: the New Haven EPESE cohort. Established populations for epidemiologic studies of the elderly, Am J Public Health, 84, 1807, 10.2105/AJPH.84.11.1807 Fitzgerald, 1988, The care of elderly patients with hip fracture, N Eng J Med, 319, 241, 10.1056/NEJM198811243192106 Ivers, 2003, Visual risk factors for hip fracture in older people, J Am Geriatr Soc, 51, 356, 10.1046/j.1532-5415.2003.51109.x Glynn, 1991, Falls in elderly patients with glaucoma, Arch Ophthalmol, 109, 205, 10.1001/archopht.1991.01080020051041 Ivers, 2000, Visual impairment and risk of hip fracture, Am J Epidemiol, 152, 633, 10.1093/aje/152.7.633 Lord, 2000, Visual contributions to postural stability in older adults, Gerontology, 46, 306, 10.1159/000022182 Anand, 2003, Postural stability changes in the elderly with cataract simulation and refractive blur, Invest Ophthalmol Visi Sci, 44, 4670, 10.1167/iovs.03-0455 Startzell, 2000, Stair negotiation in older people: a review, J Am Geriatr Soc, 48, 567, 10.1111/j.1532-5415.2000.tb05006.x Szylick JS, W Fishaman, GA, Alzexander KR, et al. Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa. Ophthalmology 2001;108:65-67. Johnson, 2006, Multifocal spectacles increase variability in toe clearance and risk of tripping in the elderly, Invest Ophthal Vis Sci, 48, 1466, 10.1167/iovs.06-0586 Lord, 2002, Multifocal glasses impair edge-contrast sensitivity and depth perception and increase the risk of falls in older people, J Am Geriatric Soc, 50, 1760, 10.1046/j.1532-5415.2002.50502.x